Symptoms of Anxiety, Burnout, and PTSD and the Mitigation Effect of Serologic Testing in Emergency Department Personnel During the COVID-19 Pandemic

Autor: Robert M. Rodriguez, Juan Carlos C. Montoy, Karin F. Hoth, David A. Talan, Karisa K. Harland, Patrick Ten Eyck, William Mower, Anusha Krishnadasan, Scott Santibanez, Nicholas Mohr, Monica Bahamon, Jestin N. Carlson, Makini Chisolm-Straker, Brian Driver, Brett Faine, Pharm D, James Galbraith, Philip A. Giordano, John P. Haran, Amanda Higgins, Jeremiah Hinson, Stacey House, Ahamed H. Idris, Efrat Kean, Elizabeth Krebs, Michael C. Kurz, Lilly Lee, Stephen Y. Liang, Stephen C. Lim, Gregory Moran, Utsav Nandi, Kavitha Pathmarajah, James H. Paxton, Yesenia Perez, Richard Rothman, Walter A. Schrading, Jessica Shuck, Patricia Slev, Howard A. Smithline, Kimberly Souffront, Mark Steele, Michelle St. Romain, Amy Stubbs, Morgan Swanson, Josh Tiao, Jesus R. Torres, Stacy Trent, Lisandra Uribe, Arvind Venkat, Gregory Volturo, Kelli Wallace, Kurt D. Weber
Rok vydání: 2020
Předmět:
Zdroj: Annals of Emergency Medicine
ISSN: 1097-6760
Popis: Study Objective Among a comprehensive range of frontline emergency department health care personnel, we assessed symptoms of anxiety and burnout, specific coronavirus disease 2019 (COVID-19) work-related stressors, and risk for post-traumatic stress disorder (PTSD). We also determined whether COVID-19 serologic testing of HCP decreased their self-reported anxiety. Methods In a prospective cohort study from May 13, 2020, to July 8, 2020, we used electronic surveys to capture participant self-reported symptoms before and after serologic testing for anti-SARS-CoV-2 immunoglobulin G antibodies. Participants were physicians, nurses, advanced practice providers, and nonclinical ED personnel at 20 geographically diverse United States EDs. We evaluated these domains: 1) the effects of the COVID-19 pandemic on overall stress and anxiety; 2) COVID-19-related work stressors; 3) burnout; and 4) PTSD risk (measured using the Primary Care-PTSD Screen for DSM-5, a 5-item screening instrument in which a score of ≥3 signifies high risk for PTSD). We also assessed perceptions of whether results of COVID-19 antibody testing decreased participants’ self-reported anxiety. Results Of 1,606 participants, 100% and 88% responded to the baseline and follow-up surveys, respectively. At baseline, approximately half (46%) reported symptoms of emotional exhaustion and burnout from their work, and 308 (19.2%, 95% confidence interval [CI] 17.3% to 21.1%) respondents screened positive for increased PTSD risk. Female respondents were more likely than males to screen positive (odds ratio [OR] 2.03, 95% CI 1.49 to 2.78). Common concerns included exposing their family and the health of coworkers diagnosed with COVID-19. After receiving antibody test results, 54% (95% CI 51.8 to 56.7) somewhat agreed, agreed, or strongly agreed that knowledge of their immune status had decreased their anxiety. A positive serology result indicating prior SARS-CoV-2 infection was associated with a higher likelihood of reporting decreased anxiety (2.83, 95% CI 1.37 to 5.83). Conclusion Symptoms of anxiety and burnout were prevalent across the spectrum of ED staff during the COVID-19 pandemic. One-fifth of ED personnel appeared to be at risk for PTSD. Increased provision of serologic testing may help to mitigate anxiety.
Databáze: OpenAIRE
Externí odkaz: